Skip to content

This Site is Intended for Healthcare Professionals Only

Search AI Powered

Latest Stories

Poll finds big support for FSA's warning to CBD industry

A new YouGov poll has demonstrated an overwhelming support for the recent Food Standards Agency (FSA) guidance on CBD products.

The poll was commissioned by the Association for the Cannabinoid Industry (ACI).


Asked how much they supported or opposed the guidance - following an FSA review on the evidence of CBD products - 74 per cent returned a positive response, while only 8 per cent chose to oppose.

The poll also gave insight into CBD usage and awareness in the UK with over 70 per cent of

respondents saying they were aware of CBD products and 16 confirming to have already made purchases.

However, while only 29 per cent have expressed their confidence in CBD products, 45 per cent of the respondents are not confident that CBD products are labelled with the correct information and are properly tested by a regulatory authority.

Dr Andy Yates, ACI's Pharmacy Lead commented: “This new poll demonstrates that the public have a clear view regarding regulation of CBD; they want more of it and the FSA can be assured that they have overwhelming support for the new measures they have introduced.”

Among the 74 per cent respondents supporting FCA’s decision, 35 per cent said they ‘strongly support,’ while 39 per cent said they ‘tend to support’.

Dr Parveen Bhatarah, ACI Regulatory Lead, said: “Recently the FSA has taken a positive step by providing regulatory clarity. This will lay the foundations of a legal and trustworthy CBD industry in the UK. The public is very aware of this and their positive reaction to guidance from the FSA reinforces the need for such leadership.”

More For You

Air pollution in UK linked to thousands of deaths and chronic health conditions

A report by the Royal College of Physicians claims that air pollution was causing harm to almost every organ of the body.

iStock

Royal College of Physicians paints grim picture of air pollution in UK

Doctors warn that around 99 per cent of the population in the UK are breathing "toxic air", and around 30,000 deaths will be linked to air pollution in 2025.

The Royal College of Physicians (RCP) claimed in a report that air pollution was causing harm to almost every organ of the body, and shortening life by 1.8 years on average.

Keep ReadingShow less
Community pharmacies falling behind on data security toolkit submissions

The last date for submission is 30 June 2025.

Pic credit: iStock

Community pharmacies falling behind on data security toolkit submissions

More than 50 per cent of the community pharmacies in England have failed to complete their Data Security and Protection Toolkit 2025 with the deadline in less than two weeks.

Necessary guidance regarding the toolkit has previously been provided by Community Pharmacy England (CPE) earlier.

Keep ReadingShow less
Digital guide launched to help patients with osteoporosis

In the UK, over three million people have osteoporosis.

Pic credit: iStock

Digital guide launched to help patients with osteoporosis

The Royal Osteoporosis Society (ROS) has launched a free online service called BoneMed which is aimed to support patients with osteoporosis in taking their medicine and remove barriers to adherence.

After completing a five-minute online survey, patients will be emailed a summary of the medicine they have been prescribed and six further updates throughout the year on their medication.

Keep ReadingShow less
GPhC five-year plan to empower pharmacists, uphold public trust

GPhC's Strategic Plan 2025-30 will focus on empowering pharmacists and pharmacy technicians.

iStock

GPhC five-year plan to empower pharmacists, uphold public trust

The General Pharmaceutical Council (GPhC) launched its new plan for the next five years to uphold safety, quality and public trust in pharmacy.

The regulatory body unveiled its Strategic Plan 2025-30 during a Parliamentary event attended by pharmacy minister Stephen Kinnock on Wednesday (18).

Keep ReadingShow less
Glucose monitor and test strips on a blood sugar tracker sheet with lancets and pen device.

Medical device manufacturers will have to monitor the safety and performance of their products already in use.

iStock

Medical device regulation overhauled to improve patients' safety

Medical device manufacturers must now adhere to the UK's post-market surveillance (PMS) regulations.

The new rule came into effect on June 16, and manufacturers will have to monitor the safety and performance of their products already in use.

Keep ReadingShow less